Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Net Margin (2023 - 2025)

Historic Net Margin for Mereo BioPharma (MREO) over the last 2 years, with Q2 2025 value amounting to 2923.2%.

  • Mereo BioPharma's Net Margin changed N/A to 2923.2% in Q2 2025 from the same period last year, while for Sep 2025 it was 12991.56%, marking a year-over-year decrease of 84599600.0%. This contributed to the annual value of 294.66% for FY2023, which is N/A changed from last year.
  • Per Mereo BioPharma's latest filing, its Net Margin stood at 2923.2% for Q2 2025.
  • Mereo BioPharma's Net Margin's 5-year high stood at 7159.44% during Q1 2025, with a 5-year trough of 2923.2% in Q2 2025.